HE4 Has a Role in Treatment Planning in Endometrial Cancer

被引：0
|
作者：
O'Toole, Sharon
Shireen, Rizmee
McDonald, Seamus
Norris, Lucy
Cooney, Anthony
AbuSaadeh, Feras
Kamran, Waseem
Murphy, Cliona
Farah, Nadine
D'Arcy, Tom
Gleeson, Noreen
O'Leary, John J.
机构：
[1] Univ Dublin Trinity Coll, Dublin 2, Ireland
[2] St James Hosp, Dublin 8, Ireland
[3] Coombe Womens & Infants Univ Hosp, Dublin, Ireland
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1191
引用
收藏
页码：300A / 300A
页数：1
相关论文
共 50 条
  • [21] HE4 is a Beneficial Biomarker in Endometrial Adenocarcinoma
    Mohammad, Hayam Fathy
    El-Khazragy, Nashwa
    Hassan, S.
    Abukra, Fatma
    Abdelrahman, Rehab M.
    Riad, Amr Ahmed Mahmoud
    Abdelhafeez, Mohamed A.
    CURRENT WOMENS HEALTH REVIEWS, 2022, 18 (02) : 141 - 148
  • [22] The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program
    Angioli, Roberto
    Capriglione, Stella
    Scaletta, Giuseppe
    Aloisi, Alessia
    Miranda, Andrea
    Nardone, Carlo De Cicco
    Terranova, Corrado
    Plotti, Francesco
    TUMOR BIOLOGY, 2016, 37 (04) : 4973 - 4978
  • [23] Role of serum HE4 in studying ovarian cancer progression and response to therapy with ARCHITECT HE4 assay
    Kenney, D.
    Radwan, R.
    Zhu, L.
    Burkhart, B.
    Glover, C.
    Vasko, A.
    Young, J.
    Acon, B.
    Polkowski, J.
    Raju, S.
    Falcone, K.
    Li, Z.
    Dickson, D.
    Simamora, R.
    Kettlety, T.
    Barnes, G.
    CANCER RESEARCH, 2010, 70
  • [24] Role of serum HE4 in studying ovarian cancer progression and response to therapy with ARCHITECT HE4 assay
    Kenney, D.
    Radwan, R.
    Zhu, L.
    Burkhart, B.
    Glover, C.
    Vasko, A.
    Young, J.
    Acon, B.
    Polkowski, J.
    Raju, S.
    Falcone, K.
    Li, Z.
    Dickson, D.
    Simamora, R.
    Kettlety, T.
    Barnes, G.
    CANCER RESEARCH, 2010, 70
  • [25] Serum HE4 predicts progestin treatment response in endometrial cancer and atypical hyperplasia: A prognostic study
    Barr, Chloe E.
    Sergeant, Jamie C.
    Agnew, Heather J.
    Bolton, James
    McVey, Rhona J.
    Crosbie, Emma J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023, 130 (08) : 941 - 948
  • [26] Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
    Cymbaluk-Ploska, Aneta
    Gargulinska, Paula
    Bulsa, Michal
    Kwiatkowski, Sebastian
    Chudecka-Glaz, Anita
    Michalczyk, Kaja
    DIAGNOSTICS, 2021, 11 (04)
  • [27] Role of Human Epididymis Protein 4 (HE4) in Determining Survival of Patients With Endometrial Cancer: A Meta-Analysis
    He, Ying
    Wang, Jing
    Ma, Chun-Xing
    Kang, Yan-Hua
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [28] The clinical significance of DJ-1 and HE4 in patients with endometrial cancer
    Benati, Marco
    Montagnana, Martina
    Danese, Elisa
    Paviati, Elisa
    Giudici, Silvia
    Ruzzenente, Orazio
    Franchi, Massimo
    Lippi, Giuseppe
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (01)
  • [29] Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer
    Kalogera, Eleftheria
    Scholler, Nathalie
    Powless, Cecelia
    Weaver, Amy
    Drapkin, Ronny
    Li, Jinping
    Jiang, Shi-Wen
    Podratz, Karl
    Urban, Nicole
    Dowdy, Sean C.
    GYNECOLOGIC ONCOLOGY, 2012, 124 (02) : 270 - 275
  • [30] Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer
    A Stiekema
    CAR Lok
    CM Korse
    WJ van Driel
    V van der Noort
    GG Kenter
    KK Van de Vijver
    Virchows Archiv, 2017, 470 : 655 - 664
12345